Glucagon Receptor Antagonist, Control
|
|
Glucagon Receptor Antagonist, Control Eigenschaften
- Siedepunkt:
- 490.8±45.0 °C(Predicted)
- Dichte
- 1.38±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- DMSO: Soluble
- Aggregatzustand
- A crystalline solid
- pka
- 11.83±0.40(Predicted)
Sicherheit
Glucagon Receptor Antagonist, Control Chemische Eigenschaften,Einsatz,Produktion Methoden
Glucagon Receptor Antagonist, Control Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Glucagon Receptor Antagonist, Control Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 8)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
Shanghai Hongye Biotechnology Co. Ltd | 400-9205774 |
sales@glpbio.cn | China | 6777 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 |
customer_service@efebio.com | China | 11974 | 58 |
TargetMol Chemicals Inc. | 15002134094 |
marketing@targetmol.cn | China | 19704 | 58 |
- Glucagon Receptor Antagonist, Control
- 4-bromo-N-[3-cyano-6-(2-methylbutan-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]benzamide
- Glucagon Receptor Antagonist Inactive Control
- Benzamide, 4-bromo-N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-
- 4-bromo-N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-benzamide
- 362482-00-6